We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Hikma Pharmaceuticals Plc | LSE:HIK | London | Ordinary Share | GB00B0LCW083 | ORD SHS 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
18.00 | 0.93% | 1,953.00 | 1,951.00 | 1,952.00 | 1,959.00 | 1,919.00 | 1,932.00 | 801,595 | 16:35:05 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 2.88B | 192M | 0.8653 | 22.56 | 4.29B |
Date | Subject | Author | Discuss |
---|---|---|---|
20/2/2018 07:26 | Teva chap joins Hikma. I'm not seeing this as a bad thing.. | r ball | |
19/2/2018 12:29 | Thanks Mr T - I'm assuming market sentiment is upbeat? Or should I place these HIKshares firmly at the bottom of my in-tray until 45th Julember? :-/ | nickg100 | |
19/2/2018 09:20 | it may be worth a buy at 9.10 given results out very soon and assume made a small profit could make a 10/20% gain over a short period. of course if good news about products that will help and no cash burn but a risk still but could have bottom may be at last | mrthomas | |
17/2/2018 19:13 | In view of Hikma's 52 week high of 2346p.... ..meeting us half way on the share price with "less negative' news will, without doubt, turn this dog into a diamond! Here's to blue and bullish forth coming week with Hikma. A well tipped and fancied company at the start of 2018. Is this Hikma's chance to shine?? | nickg100 | |
17/2/2018 18:08 | At least less megative. It would be a brave analyst to disagree with buffett | r ball | |
17/2/2018 11:04 | Have we now reason & optimism to be bullish about Hikma? | nickg100 | |
16/2/2018 20:36 | Berkshire Hathaway has bought into teva. Read across to Hikma. Has the market bottom been called? | r ball | |
09/2/2018 12:34 | Teva (NYSE) results yesterday and they were terrible.... | r ball | |
09/2/2018 11:34 | What is up with this share? Thought this was a company going places and making it happen?! | nickg100 | |
09/2/2018 10:25 | this looks very bad. its under 886p major support level..next support at 765p then 726p. take your pick. | citytrader66 | |
07/2/2018 21:26 | Q4 last yr was 4th April , this year Sharepad has Q4 as 14th March.DbD | death by donut | |
07/2/2018 19:00 | 14th March final result for 2017. I need to check, I thought this Friday they will release their Q4 2017 results. I need to check. | karateboy | |
06/2/2018 08:25 | Karate boy,what RNS are you expecting Friday? | fhmktg | |
05/2/2018 18:25 | Let's go through this Friday first. share price dropped from £22 to £9 following FDA decision last year. Any sign of resolution of this issue share price should recover.lets see what Friday RNS says about this. | karateboy | |
05/2/2018 00:04 | Not unlikely imho | isstaaz | |
03/2/2018 19:19 | Any chance of a takeover? | ianstrain | |
02/2/2018 21:29 | Next Friday is crucial for the poor share holders like me. Let's hope Hik has some good news regarding its long standing FDA application. | karateboy | |
01/2/2018 10:11 | Way oversold. JPM & co are targeting process and people costs, which are the bulk of healthcare costs. Pharma costs are a small %age | isstaaz | |
31/1/2018 09:40 | JPM, Hathaway and amazon news a downwer | bantam175 | |
23/1/2018 08:58 | You can also count on Deutsche bank to be a contra indicator..... | r ball | |
20/1/2018 19:12 | Twice HIK bounced back from 950p. Hopefully share price remains above 950p until the update in March. | karateboy | |
12/1/2018 09:50 | Full year result for 2017 to be announced on 14 March 2018. Trading update on 9th November 2017 was very positive. There is an issue beyond company's control is the devaluation of Egyptian pound. It was devalued in November from 8.8 to 17.6. So currently 17.6 Egyptian pounds buys you one USA dollar. This is good in one hand if your earning is in USA $, but makes goods produced in Egypt expensive ....I hope the company stops the share price drift south by updating the market befor 14th of March with some good news such as progress with PROGRESS with FDA submission. | karateboy | |
12/1/2018 08:54 | If its any consolation, I was holding AAL when they dropped to £2.20 and were ranked as junk status. today they are sitting at £17.54. OK its a different sector, but you never know. | richrost | |
11/1/2018 19:06 | What are your thoughts on the outlook for this to keep? I bought back then it was 16 so was thinking if I should cut losses or wait out for better times? Is it worth to wait at all? Thanks | bobogyo | |
10/1/2018 08:59 | No worries then. Just flapping their lips to feel the breeze. | bantam175 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions